These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 4944131)

  • 21. The long-term antimicrobial prophylaxis of chronic bronchitis exacerbations.
    Crimi N; Mastruzzo C; Vancheri C
    J Chemother; 1995 Aug; 7(4):307-10. PubMed ID: 8568542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protection from infection with mycobacteria.
    Stanford JL; Rook GA
    Indian J Chest Dis Allied Sci; 1983; 25(2):132-8. PubMed ID: 6360856
    [No Abstract]   [Full Text] [Related]  

  • 23. [Possibilities and limits of vaccinations].
    Schneeweiss B
    Z Arztl Fortbild (Jena); 1971 May; 65(9-10):485-95. PubMed ID: 5114862
    [No Abstract]   [Full Text] [Related]  

  • 24. Pneumococcal vaccine.
    Med Lett Drugs Ther; 1999 Sep; 41(1061):84. PubMed ID: 10505073
    [No Abstract]   [Full Text] [Related]  

  • 25. Prophylaxis for acute exacerbations of chronic bronchitis using an antibacterial sublingual vaccine obtained through mechanical lysis: a clinical and pharmacoeconomic study.
    Cogo R; Ramponi A; Scivoletto G; Rippoli R
    Acta Biomed; 2003 Aug; 74(2):81-7. PubMed ID: 14509916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pneumonia vaccine trials at Tari.
    Riley ID
    P N G Med J; 2002; 45(1-2):44-50. PubMed ID: 14658827
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mucosal vaccination against bacterial respiratory infections.
    Baumann U
    Expert Rev Vaccines; 2008 Oct; 7(8):1257-76. PubMed ID: 18844598
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vaccine trials in leprosy--Venezuela, Malawi and India.
    Gupte MD
    Int J Lepr Other Mycobact Dis; 1999 Dec; 67(4 Suppl):S32-7. PubMed ID: 10700935
    [No Abstract]   [Full Text] [Related]  

  • 29. [An oral enteritis-vaccine composed of twelve heat-inactivated Enterobacteriaceae 3. Communication: studies on efficacy tests in mice protection tests (author's transl)].
    Raettig H
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981 Nov; 250(4):511-20. PubMed ID: 7036591
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral vaccination with liposome-encapsulated recombinant fusion peptide of urease B epitope and cholera toxin B subunit affords prophylactic and therapeutic effects against H. pylori infection in BALB/c mice.
    Zhao W; Wu W; Xu X
    Vaccine; 2007 Nov; 25(44):7664-73. PubMed ID: 17913305
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Operational problems in vaccine trials.
    Guld J
    Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):559-62. PubMed ID: 6368421
    [No Abstract]   [Full Text] [Related]  

  • 32. Pneumococcal vaccine: a second look. Solution for SC or IM injection: pneumococcal vaccine.
    Prescrire Int; 1998 Feb; 7(33):16-8. PubMed ID: 10183394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Immuno-microbiological and clinical evaluation of the efficacy of topical vaccine therapy with Dentovax in patients with gingival and periodontal infections].
    De Rysky S; Menghini P; Corridori S; Concia E; Trespi G; Averna R
    Minerva Stomatol; 1983; 32(3):441-51. PubMed ID: 6350842
    [No Abstract]   [Full Text] [Related]  

  • 34. Experimental study of the mixed (oral-intradermal) vaccination method in enteric diseases.
    Dimache G; Croitoru M; Dimache A
    Roum Arch Microbiol Immunol; 1996; 55(3):215-23. PubMed ID: 9256023
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent changes in vaccination guidelines. An update on vaccines and target population initiatives.
    Dodds ES; May DB; Drew RH
    N C Med J; 2000; 61(6):326-32. PubMed ID: 11103607
    [No Abstract]   [Full Text] [Related]  

  • 36. Pneumococcal polysaccharide vaccine. Recommendation of the Immunization Practices Advisory Committee.
    Ann Intern Med; 1982 Feb; 96(2):203-5. PubMed ID: 6277218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Supplementation with zinc, but not vitamin A, improves seroconversion to vibriocidal antibody in children given an oral cholera vaccine.
    Albert MJ; Qadri F; Wahed MA; Ahmed T; Rahman AS; Ahmed F; Bhuiyan NA; Zaman K; Baqui AH; Clemens JD; Black RE
    J Infect Dis; 2003 Mar; 187(6):909-13. PubMed ID: 12660937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outbreaks of group B meningococcal disease--Florida, 1995 and 1997.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1998 Oct; 47(39):833-7. PubMed ID: 9780239
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral, inactivated, whole cell enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine: results of the initial evaluation in children. PRIDE Study Group.
    Savarino SJ; Hall ER; Bassily S; Brown FM; Youssef F; Wierzba TF; Peruski L; El-Masry NA; Safwat M; Rao M; El Mohamady H; Abu-Elyazeed R; Naficy A; Svennerholm AM; Jertborn M; Lee YJ; Clemens JD
    J Infect Dis; 1999 Jan; 179(1):107-14. PubMed ID: 9841829
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sensitization and reactogenicity of two doses of candidate antileprosy vaccine Mycobacterium w.
    Gupte MD; Vallishayee RS; Anantharaman DS; Britto RL; Nagaraju B
    Indian J Lepr; 1996; 68(4):315-24. PubMed ID: 9001899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.